As part of MUSC's growing transnational genomics program, a genomics tumor board has been created to bring diverse specialists together to help physicians diagnose and manage cancer.The genomics team's expertise, as well as the next generation sequencing that analyzes tumor samples, is also available to all of South Carolina's oncologists and their patients.

More at Progressnotes, MUSC’s Medical Magazine